🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2017-06-12
Trial ID
NCT03160885
Treatments Being Tested
A 52-Week, Open-Label, Multicentre Study to Evaluate the Safety of Tralokin...
Status
Terminated
Location
Research Site
Start Date
2016-11-11
Trial ID
NCT02902809
Treatments Being Tested
The aim of the study is to evaluate the efficacy and safety of tralokinumab...
Status
Completed
Location
Research Site
Start Date
2015-01-23
Trial ID
NCT02347176
Treatments Being Tested
The purpose of this trial is to investigate if tralokinumab changes the met...
Status
Completed
Location
LEO Pharma Investigational Site
Start Date
2018-08-13
Trial ID
NCT03556592
Treatments Being Tested
Primary objective: To evaluate the efficacy of subcutaneous (SC) administr...
Status
Completed
Location
LEO Pharma Investigational Site
Start Date
2018-06-19
Trial ID
NCT03526861
Treatments Being Tested
To study the safety and effectiveness of multiple-doses of tralokinumab on ...
Status
Terminated
Location
Research Site
Start Date
2012-10
Trial ID
NCT01629667
Treatments Being Tested
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-05-30
Trial ID
NCT03131648
Treatments Being Tested
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Celerion
Start Date
2014-03-19
Trial ID
NCT02085473
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The purpose of this study is to determine whether the addition of tralokinu...
Status
Completed
Location
Research Site
Start Date
2011-08
Trial ID
NCT01402986
Treatments Being Tested